Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers

Gynecologic Oncology

Volumn 71, Issue 1, 1998, Pages 77-82

  Wiper, Donald W ^b   Zanotti, Kristine M ^b   Kennedy, Alexander W ^b   Belinson, Jerome L ^b   Casey, Graham ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER GROWTH; CANCER STAGING; CHROMOSOME 17P; CHROMOSOME ANALYSIS; EPITHELIUM CELL; FEMALE; GENE LOCUS; GENETIC STABILITY; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT; TUMOR SUPPRESSOR GENE;

EID: 0032190682     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5110     Document Type: Article

References (44)

1. Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
2. Yang-Feng T.L, Han H, Chen K C, Li S B, Claus E B, Carcangiu M L, Chambers S K, Chambers J T, Schwartz P E. Allelic loss in ovarian cancer. Int J Cancer. 54:1993;546-551.
3. Cliby W, Ritland S, Hartmann L, Dodson M, Halling K C, Keeney G, Podratz K C, Jenkins R B. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398.
4. Osborne R J, Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer. 69:1994;429-438.
5. Shelling A N, Cooke I E, Ganesan T S. The genetic analysis of ovarian cancer. Br J Cancer. 72:1995;521-527.
6. Tavassoli M, Ruhrberg C, Beaumont V, Reynolds K, Kirkham N, Collins W P, Farzaneh F. Whole chromosome 17 loss in ovarian cancer. Genes Chromosomes Cancer. 8:1993;195-198.
7. Foulkes W D, Black D M, Stamp G W, Solomon E, Trowsdale J. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer. 54:1993;220-225.
8. Pieretti M, Cavalieri C, Conway P S, Gallion H H, Powell D E, Turker M S. Genetic alterations distinguish different types of ovarian tumors. Int J Cancer. 64:1995;434-440.
9. Phillips N, Ziegler M, Saha B, Xynos F. Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer. 54:1993;85-91.
10. Slamon D J, Godophin W, Jones L A, Holt J A, Wong S G, Keith D E, Levin W J, Stuart S G, Udove J, Ullrich A, Press M F. Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707-712.
11. Marks J R, Davidoff A M, Kerns B J, Humphrey P A, Pence J C, Dodge R K, Clarke-Pearson D L, Iglehart J D, Bast R CJ, Berchuck A. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res. 51:1991;2979-2984.
12. Berchuck A, Kohler M F, Marks J R, Wiseman R, Boyd J, Bast R C. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet. Gynecol. 170:1994;246-252.
13. Berchuck A, Kohler M F, Hopkins M P, Humphrey P A, Robboy S J, Rodriguez G C, Soper J T, Clarke-Pearson D L, Bast R C. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol. 52:1994;232-236.
14. Casey G, Lopez M E, Carlos J, Plummer S J, Arboleda J E, Shaughnessy M, Karlan B, Slamon D A. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene. 13:1996;1971-1981.
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P A, Harshman K, Tavtigian S, Kiu Q, Cochran C, Bennett L M, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P K, Norris F H, Helvering L, Morrison P, Rosteck P, Lai M, Barrett J C, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R AK, Skolnick M H. A strong candidate for the breast ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
16. Ponder B AJ. Gene losses in human tumours. Nature. 335:1988;400-401.
17. Eeles R A, Bartkova J, Lane D P, Bartek J. The role of TP53 in breast cancer development. Cancer Surv. 18:1993;57-75.
18. Wales M M, Biel M A, el Deiry W, Nelkin B D, Issa J P, Cavenee W K, Juerbitz S, Baylin S B. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1:1995;570-577.
19. Phillips N J, Ziegler M R, Radford D M, Fair K L, Steinbrueck T, Xynos F P, Donis-Keller H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56:1996;606-611.
20. Schultz D C, Vanderveer L, Berman D B, Hamilton T C, Wong A J, Godwin A K. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res. 56:1996;1997-2002.
21. Wertheim I, Tangir J, Muto M G, Welch W R, Berkowitz R S, Chen W Y, Mok S C. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene. 12:1996;2147-2153.
22. Mackay J, Steel C M, Elder P A, Forrest A PM, Evans H J. Allele loss on short arm of chromosome 17 in breast cancers. Lancet. 2:1988;1384-1385.
23. Cornelis R S, van Vliet M, Vos C B, Cleton-Jansen A M, van de Vijver M J, Peterse J L, Khan P M, Borresen A L, Cornelisse C J, Devilee P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res. 54:1994;4200-4206.
24. Nagai M A, Medeiros A C, Brentani M M, Brentani R R, Marques L A, Mazoyer S, Mulligan L M. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology. 52:1995;448-453.
25. Stack M, Jones D, White G, Liscia D S, Venesio T, Casey G, Crichton D, Varley J, Mitchell E, Heighway J, Santibanez-Koref M. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum Mol Genets. 4:1995;2047-2055.
26. Radford D M, Fair K L, Phillips N J, Ritter J H, Steinbrueck T, Holt M S, Donis-Keller H. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res. 55:1995;3399-3405.
27. Biegel J A, Burk C D, Barr F G, Emanuel B S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. 52:1992;3391-3395.
28. Haataja L, Raffel C, Ledbetter D H, Tanigami A, Petersen D, Heisterkamp N, Groffen J. Deletion within the D17S34 locus in a primitive neuroectodermal tumor. Cancer Res. 57:1997;32-34.
29. Atkin N B, Baker M C. Chromosome 17 loss in carcinoma of the cervix uteri. Cancer Genet Cytogenet. 37:1989;229-233.
30. Saylors R, Sidransky D, Friedman H S, Bigner S H, Vogelstein B, Brodeur G M. Infrequent p53 gene mutations in medulloblastomas. Cancer Rese. 51:1991;4721-4723.
31. Cogen P H, Daneshvar L, Metzger A K, Duyk G, Edwards M SB, Sheffield V C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet. 50:1992;584-589.
32. McDonald J D, Daneshvar L, Willert J R, Matsumura K, Waldman F, Cogen P H. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics. 23:1994;229-232.
33. Toguchida J, Ishizaki K, Sasaki M S, Ikenaga M, Kato M, Sugimoto M, Kotoura Y, Yamamuro T. Assignment of a common allele loss in osteosarcoma to the subregion 17p13. Cancer Res. 49:1989;6247-6251.
34. Saxena A, Clark W C, Robertson J T, Ikejiri B, Oldfield E H, Ali I. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res. 52:1992;6716-6721.
35. Phillips N J, Zeigler M R, Deaven L L. A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3. Cancer Lett. 102:1996;85-90.
36. Devilee P, Cornelisse C J. Somatic genetic changes in human breast cancer. Biochim Biophys Acta. 1198:1994;113-130.
37. Plummer S J, Paris M J, Myles J, Tubbs R, Crowe J, Casey G. Four regions of allelic imbalance on chromosome 17q12-qter associated with high-grade breast tumors. Genes, Chromosomes Cancer. 20:1997;1-9.
38. Mok C H, Tsao S W, Knapp R C, Fishbaugh P M, Lau C C. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res. 52:1992;5119-5122.
39. Teneriello M G, Ebina M, Limnoila R I, Henry M, Nash J D, Park R C, Birrer M J. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53:1993;3103-3108.
40. Kupryjanczyk J, Thor A D, Beauchamp R, Merritt V, Edgerton S M, Bell D A, Yandell D W. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA. 90:1993;4961-4965.
41. Sakamoto T, Nomura N, Mori H, Wake N. Poor correlation with loss of heterozygosity on chromosome 17pand p53 mutations in ovarian cancers. Gynecol Oncol. 63:1996;173-179.
42. Papp J, Csokay B, Bosze B, Zalay Z, Toth J, Ponder B, Olah E. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. Br J Cancer. 74:1996;1592-1597.
43. White G R, Stack M, Santibanez-Koref M, Liscia D S, Venesio T, Wang J C, Helms C, Donis-Keller H, Betticher D C, Altermatt H J, Hoban P R, Heighway J. High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor. Br J Cancer. 74:1996;863-870.
44. Martens U M, Zijlmans J M, Poon S S, Dragowska W, Yui J, Chavez E A, Ward R K, Lansdorp P M. Short telomeres on human chromosome 17p. Nature Genet. 18:1998;76-80.